Área de Nutrición y Bromatología, Facultad de Farmacia, Universidad de Salamanca, Salamanca, Spain.
Curr Med Chem. 2019;26(39):6976-6990. doi: 10.2174/0929867325666180706104829.
Flavonoids are phenolic compounds widely distributed in the human diet. Their intake has been associated with a decreased risk of different diseases such as cancer, immune dysfunction or coronary heart disease. However, the knowledge about the mechanisms behind their in vivo activity is limited and still under discussion. For years, their bioactivity was associated with the direct antioxidant and radical scavenging properties of phenolic compounds, but nowadays this assumption is unlikely to explain their putative health effects, or at least to be the only explanation for them. New hypotheses about possible mechanisms have been postulated, including the influence of the interaction of polyphenols and gut microbiota and also the possibility that flavonoids or their metabolites could modify gene expression or act as potential modulators of intracellular signaling cascades. This paper reviews all these topics, from the classical view as antioxidants in the context of the Oxidative Stress theory to the most recent tendencies related with the modulation of redox signaling pathways, modification of gene expression or interactions with the intestinal microbiota. The use of C. elegans as a model organism for the study of the molecular mechanisms involved in biological activity of flavonoids is also discussed.
类黄酮是广泛存在于人类饮食中的酚类化合物。它们的摄入与降低多种疾病的风险有关,如癌症、免疫功能障碍或冠心病。然而,关于它们在体内活性背后的机制的知识是有限的,仍在讨论中。多年来,它们的生物活性与酚类化合物的直接抗氧化和自由基清除特性有关,但如今,这种假设不太可能解释它们潜在的健康影响,或者至少不可能是唯一的解释。已经提出了关于可能的机制的新假设,包括多酚与肠道微生物群相互作用的影响,以及类黄酮或其代谢物可能改变基因表达或作为细胞内信号级联的潜在调节剂的可能性。本文综述了所有这些主题,从氧化应激理论背景下作为抗氧化剂的经典观点到与调节氧化还原信号通路、修饰基因表达或与肠道微生物群相互作用相关的最新趋势。还讨论了使用秀丽隐杆线虫作为研究类黄酮生物活性相关分子机制的模式生物。